“did not reach statistical significance”

Although showing a clear trend, the difference did not reach statistical significance ( P =.13).

The correlation between DFS and disease recurrence after cCR did not reach statistical significance, although it did show a positive trend (mDFS in patients recurring after cCR: 357.0 days vs. mDFS in patients not recurring after cCR: 712.0 days, P = .13).

It showed a trend towards the association that did not reach statistical significance ( p = 0.13).

Women who underwent early PBO also showed a trend of greater tau deposition compared to the referent women after adjusting for age (PBO p = 0.13), or for age and APOE ε4 status (PBO p = 0.16), but this difference did not reach statistical significance (Table 2 ).

However, brachial DBP reduction did not reach statistical significance but showed a trend toward decrease (−5.10 mmHg [95% CI: −11.71 to 1.52], p = 0.13).

Although patients with VEGFC levels above the optimal cutoff of 23.471 pg/mL showed a trend toward shorter PFS (hazard ratio: 1.4 [0.73-2.7], P = 0.13; Figure S7 A-B ), this association did not reach statistical significance.

Similarly, in Leone's VECTIBIL trial, the addition of panitumumab showed a trend towards enhanced overall survival (OS) advantage in ICC patients (15.1 months vs 11.8 months, p = 0.13) [ 23 ], although this result did not reach statistical significance.

While diabetes mellitus showed a trend toward association with HFpEF in univariate analysis (OR 1.33, 95% CI 0.92–1.92, P = 0.13), it did not reach statistical significance for inclusion in our final model. 3.3.

While there was a clear trend towards increased clearance time with increasing rHuEpo dose the effect did not reach statistical significance (Mann-Whitney U test, P=0.13).

A negative trend was observed between Cluster Shade and eGFR (ρ = − 0.27, p = 0.13), although it did not reach statistical significance.

In contrast, although eNOS expression showed an increasing trend, the change did not reach statistical significance ( p = 0.131).

Smoking history showed a trend toward increased recurrence risk with a HR of 1.61 (95% CI 0.85–3.04, p = 0.14), though this did not reach statistical significance.

Although there was a clear trend towards fewer complications in the UBE group, the difference in total incidence between the 2 groups did not reach statistical significance ( P =0.14).

The group with stage IB1 tumors >2 cm had statistically deeper cervical stromal invasion (9.99±5.04 mm, p<0.001, Kruskal-Wallis test), higher incidences of LVSI (45.3%, p = 0.002, chi-square test), and greater lymph node metastasis (24.2%, p = 0.002, chi-square test) compared to the other 2 groups (stage IA2 and stage IB tumors ≤2 cm).The group with stage IB1 tumors >2 cm showed a trend toward a higher incidence of parametrial invasion (9.5%, p = 0.14, chi-square test) compared with the other two groups (stage IA2 tumor, 0%;stage IB1 tumor ≤2 cm, 4%), though it did not reach statistical significance.

While there was a clear trend towards an increase in both basal (mean difference=2.59, P =0.14) and 30-minute cortisol values (mean difference=1.94, P =0.32), these values did not reach statistical significance.

While the age group distribution showed a trend toward higher medical use among the 65+ cohort (62.3%), this did not reach statistical significance in the bivariate analysis ( p = 0.143).

Although patients with elevated miR-96 expression levels showed a trend toward reduced survival probability, the Kaplan–Meier analysis did not reach statistical significance ( P = 0.15), so the sample size ( n = 79) may have contributed to insufficient statistical power.

Although mitotic activity and vascular invasion showed a trend toward higher levels in the high SETD5 expression group, these differences did not reach statistical significance ( p = 0.15 and p = 0.12, respectively). 3.4.

Although the reduction in pneumonia did not reach statistical significance, the antiemetic group showed a favorable trend compared with placebo (39/237 (16.5%) antiemetic, 90/278 (32.4%) placebo; mean difference 15.9%, RR = 0.44, 95% CI: 0.15–1.28, p = 0.15).

With respect to severe fibrosis, although serrated histology showed a trend toward lower rates of severe fibrosis, this association did not reach statistical significance in the multivariate analysis (OR: 0.49, 95% CI: 0.16–1.20, p = 0.15), likely due to the limited number of CSL cases presenting severe fibrosis in our cohort.

While PDCD4 expression showed a trend toward better survival in high-expressing patients, it did not reach statistical significance (HR = 0.97, 95% CI: 0.94–1.01, p = 0.152, C-index = 0.589; Supplementary Figure S3 ).

Although an increasing trend was evident after 14 days, this did not reach statistical significance ( p = 0.1525; Figure 1 C2).

A weak negative correlation ( r = −0.344) was observed that approached significance ( p = 0.162), suggesting a possible inverse relationship between DPPH and FRAP, although it did not reach statistical significance.

A high VAT-M Z -score (more visceral fat) showed a trend towards being associated with a lower risk of a grade ≥ 3b postoperative complication in univariable (RR 0.47, 95% CI 0.16–1.36, p = 0.164) and multivariable analyses (RR 0.44, 95% CI 0.14–1.40, p = 0.166), but did not reach statistical significance (Table 3 ).

Although HCY showed a positive trend ( β = 0.0545, P = 0.1651), its association did not reach statistical significance in this cohort.